| |
|
|
|
|
|
|
|
Supplement
September 2005 - Supplement II Emerging Trends and Formulary Considerations for Atypical Antipsychotics SUPPLEMENT CONTENT
- Participating Faculty
 Full Text PDF
- Atypical Antipsychotics and the Burden of Disease
George M. Simpson, MD Full Text PDF
- Healthcare Spending Among Community-dwelling Adults With Schizophrenia
Margaret McDonald, PhD; Robin P. Hertz, PhD; Michael B. Lustik, MS; and Alan N. Unger, PhD Full Text PDF
- Atypical Antipsychotics: Considerations for Medicaid Coverage
Richard C. Surles, PhD Full Text PDF
- Impact of Atypical Antipsychotics on Outcomes of Care in Schizophrenia
Amie T. Joyce, MPH; David J. Harrison, PhD; Antony D. Loebel, MD; and Daniel A. Ollendorf, MPH Full Text PDF
|
|
| |
|
Intellisphere, LLC l 666 Plainsboro Road, Building 300, Plainsboro, NJ 08536 l P 609-716-7777 l F 609-716-4747
|
 |
Copyright ©MDNG 2006-2010
Intellisphere, LLC
All Rights Reserved
|
|
|
|
|
|
